|
JP2019131619A
|
|
Antibacterial agent
|
|
JP2020183355A
|
|
Preventive and therapeutic agent of benign prostatic hypertrophy
|
|
CN111281857A
|
|
Capsule preparation
|
|
JP2017001960A
|
|
Antiinflammatory agent, antioxidant and antibacterial agent
|
|
JP2017002107A
|
|
Soil conditioner
|
|
JP2016065037A
|
|
Production method of antiviral drug and antiviral drug obtained by method thereof
|
|
JP2016164129A
|
|
Antiviral agent to animal viruses
|
|
JP2014158441A
|
|
Cultivation method of ganoderma lucidum having novel bioactivity
|
|
JP2012249631A
|
|
METHOD FOR PRODUCING β-CAROTENE-RICH DUNALIELLA POWDER
|
|
JP2013185143A
|
|
Soil conditioner
|
|
JP2013027344A
|
|
Culture method of algae and algae obtained by the culture method, and soil conditioner using medium
|
|
JP2012224554A
|
|
Antiviral agent and method for producing the same
|
|
EP2509611A1
|
|
Crude dunaliella powder for use in treating psoriasis
|
|
IL208831D0
|
|
Methods of treating ophthalmic disorders
|
|
JP2011234677A
|
|
Algae culture device
|
|
EP2296682A2
|
|
Methods of treating ophthalmic disorders
|
|
JP2010105959A
|
|
Composition containing highly pure 9-cis-beta carotene and method for preparing the same
|
|
JP2010095492A
|
|
Substance for preventing adverse effect of treating agent for dyslipidemia
|
|
JP2009263328A
|
|
Composition for treating ophthalmic medical symptom
|
|
JP2010095491A
|
|
Insulin resistance-improving agent
|
